Explore evidence

43.6 %Among male patients with sickle cell disease in Ibadan, Nigeria, who experienced priapism, sleeplessness was reported by 43.6%.

Nigeriadrépanocytosepublished 2020West African journal of medicinePubMeddocument of 9 observations

0.435 secondsThe median QTc interval was 0.435 seconds (interquartile range: 0.417–0.440 seconds) during steady-state in children with sickle cell anemia.

Nigeriadrépanocytosepublished 2021HemoglobinPubMeddocument of 5 observations

2.5 %Among 3622 enrolled sickle cell disease patients in Nigeria, the frequency of Hb SC was 2.5%.

Nigeriadrépanocytose · Hb SCpublished 2020Blood cells, molecules & diseaseseurope_pmcdocument of 16 observations

55 %About 165 out of 300 respondents (55.0%) had a positive attitude towards sickle cell disease and premarital screening.

Nigeriadrépanocytosepublished 2022The Pan African medical journalPubMeddocument of 7 observations

13 yearsThe mean age at onset of breast development (Tanner stage B2) was 13 years in girls with sickle cell anaemia.

Nigeriadrépanocytosepublished 2023West African journal of medicinePubMeddocument of 7 observations

1.45 %About 1.45% of the 138 newly diagnosed sickle cell disease patients had heterozygous sickle-hemoglobin C (SC) variant.

Nigeriadrépanocytoseobserved 2013 to 2014published 2022The Pan African medical journalPubMeddocument of 9 observations

84.8 %173 (84.8%) of the participants had a fewer need for blood transfusion while using hydroxyurea.

Nigeriadrépanocytosepublished 2022Frontiers in geneticseurope_pmcdocument of 10 observations

2.3 x10¹²/LRed blood cell count in crisis state subjects was 2.3 ± 0.7.

Nigeriadrépanocytosepublished 2022The Pan African medical journalPubMeddocument of 14 observations

0.63 %The prevalence of sickle cell disease among adults was 0.63%.

Nigeriadrépanocytoseobserved 2013 to 2014published 2022The Pan African medical journalPubMeddocument of 9 observations

There was no significant difference in the spot urine NGAL and urine NCR between the 2 groups, though both were higher in the HbS group compared to the HbA group.

Nigeriadrépanocytosepublished 2021Medical principles and practice : international journal of the Kuwait University, Health SPubMeddocument of 3 observations

9.8 %The prevalence of right ventricular diastolic dysfunction among children with sickle cell anaemia was 9.8%.

Nigeriadrépanocytose · right ventricular diastolic dysfunctionpublished 2020BMC pediatricsPubMeddocument of 8 observations

19 monthsThe average age at diagnosis of sickle cell disease was 19 months in Nigeria.

Nigeriadrépanocytosepublished 2025EJHaemeurope_pmcdocument of 7 observations

Patients with relative systemic hypertension and sickle cell anaemia had higher packed cell volumes, smaller right atria area, lower tricuspid regurgitant velocities, lower incidence of early satiety, longer QTc, and higher frequency of a history of vaso-occlusive crises compared to those without relative systemic hypertension.

Nigeriadrépanocytose · relative systemic hypertensionpublished 2020Indian heart journalPubMeddocument of 3 observations

316 patientsA cohort of 316 children aged 1–18 years with sickle cell anaemia was evaluated.

Nigeriadrépanocytosepublished 2021Journal of pediatric endocrinology & metabolism : JPEMPubMeddocument of 6 observations

0.6 %Isoelectric focusing (IEF) tests identified 3 (0.6%) HbAC phenotypes among 511 newborns.

Nigeriadrépanocytosepublished 2022Frontiers in geneticseurope_pmcdocument of 23 observations

Nigeria bears the highest global burden of sickle cell disease.

Nigeriadrépanocytosepublished 2025BMC public healthPubMeddocument of 5 observations

46.7 %46.7% of respondents expressed willingness to 'take the risk and hope for the best' regarding sickle cell disease birth risk.

Nigeriadrépanocytosepublished 2025BMC public healthPubMeddocument of 6 observations

36.5 %Among 85 sickle cell disease patients in a Nigerian hospital, 36.5% had more than three painful crises in a year.

NigeriadrépanocytosePubMeddocument of 10 observations

84.7 %The prevalence of growth failure and short stature among children aged 1–18 years with sickle cell anaemia was 84.7%.

Nigeriadrépanocytosepublished 2021Journal of pediatric endocrinology & metabolism : JPEMPubMeddocument of 6 observations

25.38 yearsThe mean age of the participants was 25.38 years among clinically stable Nigerian adults with sickle cell disease.

Nigeriadrépanocytosepublished 2020Nigerian journal of clinical practicePubMeddocument of 8 observations

100 %For 14 newborns with sickle cell disease who accepted diagnosis and were enrolled into the SCD program, HemoTypeSC had 100% sensitivity when compared with alkaline cellulose acetate hemoglobin electrophoresis (ACAE) repeated at age ≥6 months.

Nigeriadrépanocytosepublished 2024Hemoglobineurope_pmcdocument of 10 observations

The Ibadan patients did not receive hydroxyurea (HU) therapy as frequently as the Chicago patients.

Nigeriadrépanocytosepublished 2014Hemoglobineurope_pmcdocument of 5 observations

1 %Prevalence of sickle cell disease across African countries ranges between 1% and 3%.

Nigeriadrépanocytosepublished 2025Communications medicineeurope_pmcdocument of 4 observations

The weight, height, BMI, systolic blood pressure, plasma urea, plasma creatinine, and spot urine creatinine of the HbS genotype children were significantly lower compared to that of the HbA genotype children.

Nigeriadrépanocytosepublished 2021Medical principles and practice : international journal of the Kuwait University, Health SPubMeddocument of 3 observations

38.4 cm²Ulcers in patients with sickle cell anaemia ranged from 0.5 cm² to 416 cm², with a median of 38.4 cm².

Nigeriadrépanocytoseobserved 2015published 2020African journal of laboratory medicineeurope_pmcdocument of 3 observations